-
-
-
Lynk & Co Honors Exceptional Global Achievements in 2024
HANGZHOU,China,Jan. 3,2025--On January 1st,Lynk & Co announced its annual sales achievement. With 285,441 units sold worldwide,the brand has achieved a year-on-year growth of approximately 30%. In
-
-
-
-
Interest-Driven Consumption Sparks ¥ 500B ACG Goods Market, MINISO Rides the Wave
GUANGZHOU,China,Jan. 3,2025-- MINISO,a global lifestyle brand,recently announced its partnership with "Black Myth: Wukong",winner of the "Best Action Game" and "Players\' Voic
-
-
-
-
PacificLight Power Awarded Right to Build New Hydrogen-Ready Combined Cycle Gas Turbine Plant
SINGAPORE,Jan. 3,2025-- PacificLight Power Pte Ltd (PLP) is delighted to announce that it has been awarded the right to build,own,and operate a hydrogen-ready Combined Cycle Gas Turbine (CCGT) facilit
-
-
-
-
GRIT Bio Appoints Jie Jia, Ph.D., as Chief Operating Officer
SHENZHEN,China,Jan. 3,2025--Shenzhen GRIT Biotechnology Co.,Ltd.,a leading company in cell therapy globally,today announced the appointment of Jie Jia,Ph.D.,as Chief Operating Officer (COO),effective
-
-
-
-
Nona Biosciences Announces Update on Its Collaborator DualityBio's Antibody-Drug Conjugate (ADC) Collaboration with BeiGene
CAMBRIDGE,Mass.,Jan. 3,2025-- Nona Biosciences,a global biotechnology company providing a total solution from "Idea to IND" (I to ITM),today announcedthat BeiGene. Ltd. has exercised its ex
-
-
-
-
TESSAN and Rachael Yamagata Unveil a Musical Journey: Discover the World Through Song and Story
NEW YORK,Jan. 5,2025-- The leading charging solution brand TESSAN has launched a captivating documentary on YouTube featuring the talented singer-songwriter Rachael Yamagata sharing her creative exper
-
-
-
-
ICZOOM Concluded 2024 with Multiple Awards
HONG KONG,Jan. 3,2025-- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"),a B2B electronic component products e-commerce platform,announced that it concluded a successful
-
-
-
-
Innovent Announces Second New Drug Application of DOVBLERON ® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) was Approved by China's National Medical Products Administration
SAN FRANCISCO and SUZHOU,China,Jan. 3,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua
Innovent Biologics / 01-06
-
-
-
-
Global Times: China’s role as a stabilizing force crucial for 2025 and beyond
The year 2024 witnessed regional turmoil and profound landscape changes. From the Russia-Ukraine conflict to the chaos in the Middle East and the interference of external forces stirring tensions in the South China Sea, China demonstrated composure and confidence amid a turbulent landscape, creating a favorable external environment for its high-quality development and injecting valuable stability into a restless world. As a member of the Global South, China is playing an increasingly important role in promoting world development and peace, as well as advancing the rise of the Global South. As
Global Times / 01-06
-
-
-
-
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS
NANTONG and SUZHOU,China,Dec. 24,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies,today announced the successful dosing of th
-
Food
Newest
